Table 1.
Characteristics | Groups | |||
---|---|---|---|---|
Non-DM (n%) | DM (n%) | Total | P-value | |
Age (year) | ||||
<65 | 2,038 (80.5) | 287 (72.5) | 2,325 (79.4) | <0.001 |
≥65 | 495 (19.5) | 109 (27.5) | 604 (20.6) | |
Sex | ||||
Male | 1,102 (43.5) | 169 (42.7) | 1,271 (43.4) | 0.757 |
Female | 1,431 (56.5) | 227 (57.3) | 1,658 (56.6) | |
Smoking | ||||
No | 1,519 (60.0) | 249 (62.9) | 1,768 (60.4) | 0.271 |
Yes | 1,014 (40.0) | 147 (37.1) | 1,161 (39.6) | |
Alcohol consumption | ||||
No | 2,050 (80.9) | 327 (82.6) | 2,377 (81.2) | 0.437 |
Yes | 483 (19.1) | 69 (17.4) | 552 (18.8) | |
Tumor types | ||||
Lung | 773 (30.5) | 125 (31.6) | 898 (30.7) | 0.001 |
Digestive tract | 507 (20.0) | 91(23.0) | 598 (20.4) | |
Liver | 136 (5.4) | 41 (10.4) | 177 (6.0) | |
Leukemia | 284 (11.2) | 31 (7.8) | 315 (10.8) | |
Breast | 625 (24.7) | 76 (19.2) | 701(23.9) | |
Others | 208 (8.2) | 32 (8.1) | 240(8.2) | |
TNM stages | ||||
I | 448 (18.6) | 51 (13.3) | 499 (17.9) | <0.001 |
II | 569 (23.7) | 86 (22.5) | 655 (23.5) | |
III | 594 (24.7) | 131 (34.2) | 725 (26.0) | |
IV | 475 (19.8) | 85 (22.2) | 560 (20.1) | |
Leukemia | 318 (13.2) | 30 (7.8) | 348 (12.5) | |
PG-SGA | ||||
0–1 | 1,035 (40.9) | 133 (33.6) | 1,168 (39.9) | 0.002 |
2–3 | 437 (17.3) | 62 (15.7) | 499 (17.1) | |
4–8 | 744 (29.4) | 130 (32.8) | 874 (29.9) | |
≥9 | 314 (12.4) | 71 (17.9) | 385 (13.2) | |
NRS-2002 | ||||
<3 | 2,077 (90.7) | 328 (92.7) | 24,05 (90.9) | 0.224 |
≥3 | 214 (9.3) | 26 (7.3) | 240 (9.1) | |
QoL-C30 | ||||
<60 | 795 (31.5) | 140 (35.4) | 935 (32.0) | 0.117 |
≥60 | 1,730 (68.5) | 255 (64.6) | 1,985 (68.0) | |
VFA (cm2) | ||||
<90 | 1,352 (53.4) | 188 (47.5) | 1,540 (52.6) | 0.029 |
≥90 | 1,181 (46.6) | 208 (52.5) | 1,389 (47.4) |
DM, diabetes mellitus; PG-SGA, the Patient-Generated Subjective Global Assessment; NRS-2002, the Nutritional Risk Screening-2002 score; QoL-C30, quality of life; VFA, visceral fat area.